AI allows for the rational design of drugs by modeling protein-drug interactions, which significantly reduces the reliance on random trial-and-error methods.

“right, we can start actually rationally designing these drugs, right? Traditionally, you would take, you know, a million random molecules and you would just throw them at these proteins and see what sticks.”

He claims that designing proteins from scratch is superior to traditional methods because it allows for the precise engineering of therapeutic properties.

“I think more and more we're going to see random selection, random sort of library screening methods, which are kind of emulating evolution, where evolution is all random mutation generation and selection, we're going to see that replaced by intentional protein design.”